Effect of alginate composition and purity on alginate microspheres

Background: Alginate is commonly used to microencapsulate islets in experiments with islet allografts and xenografts for the treatment of Type I diabetes. The purpose of the present study is to determine the effects of alginate composition and purity oil the morphology and size of microspheres. Methods:: Microcapsules produced with the impure alginate types, medium-viscosity high-guluronic acid (IMVG), low-viscosity high-G (ILVG), low-viscosity high-mannuronic acid (ILVM) and medium-viscosity high-M (IMVM) were compared with one another and others generated with a highly purified LVM (HPLVM) alginate. Droplets of 1.5% alginate from an air-syringe pump were gelled in 1.1% CaCl2 solution. While leaving the alginate pressure and needle recess constant, the air-jacket pressure was varied between 93-10.5 PPSI to enhance stable microcapsule generation and different batches of microbeads were made from each alginate type. Results: The sizes of the high-guluronic acid alginate microbeads were consistently bigger than those of the corresponding high-mannuronic acid alginate beads at all air-jacket settings. At the optimal air-jacket pressure of 9.0 PPSI, the mean +/- SD diameter of the IMVG microbeads was 780+20 mum, while that of IMVM was 607+44 mum (p<0.0001, n=30). Similarly,, the mean ILVG microbead diameter was 816 + 28 mum compared to 656+26 mum for ILVM capsules (p<0.0001. n=30). Less polymorphism was found,with the HPLVM microspheres than with the ILVM microbeads. Conclusion: Highly purified high-mannuronic acid alginate will provide smaller, spherical microcapsules suitable for islet cell transplantation.